Equine antibodies are directed at SARS-CoV-2, they will try to disable it, so that it cannot enter a human cell and thus break, let’s say, the evolution of sequelae caused by this virus “, explained the executive president.
The objective is to stop the evolution of the sequels. “We are talking about a treatment to contain the advance to critical deterioration of people and also avoid subsequent sequelae,” said Macaya optimistically.
Macaya detailed that SARS-CoV-2 causes respiratory failure, kidney failure, multi-organ failure, blood clots, thrombosis, heart attacks, stroke, “all this caused by a single virus, that is, it is affecting many body systems.”
She drew attention to the fact that there comes a point where SARS-CoV-2 causes damage, generates sequelae and disappears, but the person can still die from these sequelae. “We have lost patients who were already negative for the virus, but were already in the ICU, fighting for respiratory failure, kidney failure and the cytokine storm, that is, everything that triggered the virus” said the hierarch.
Dr. Macaya said that the treatment seeks to stop the virus as soon as possible, so patients should receive treatment when they enter the hospital in moderate condition, “we do not want its sequelae to evolve because later it may be too late. These antibodies are designed to neutralize the culprit, the virus, but if it has already done the damage, it will no longer be reversible “